United States · FDA National Drug Code directory
Hydromorphone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-9701_b9b96266-fe94-4282-915f-277433e1ca26
- Product NDC
- 71335-9701
- Form
- TABLET
- Composition / generic term
- Hydromorphone Hydrochloride
- Labeler
- Bryant Ranch Prepack
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20091123
- Source listing expiry
- 20271231
Source-listed ingredients
- HYDROMORPHONE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 TABLET in 1 BOTTLE, PLASTIC (71335-9701-0) · 71335-9701-0
- 30 TABLET in 1 BOTTLE, PLASTIC (71335-9701-1) · 71335-9701-1
- 180 TABLET in 1 BOTTLE, PLASTIC (71335-9701-2) · 71335-9701-2
- 120 TABLET in 1 BOTTLE, PLASTIC (71335-9701-3) · 71335-9701-3
- 20 TABLET in 1 BOTTLE, PLASTIC (71335-9701-4) · 71335-9701-4
- 25 TABLET in 1 BOTTLE, PLASTIC (71335-9701-5) · 71335-9701-5
- 100 TABLET in 1 BOTTLE, PLASTIC (71335-9701-6) · 71335-9701-6
- 60 TABLET in 1 BOTTLE, PLASTIC (71335-9701-7) · 71335-9701-7
- 56 TABLET in 1 BOTTLE, PLASTIC (71335-9701-8) · 71335-9701-8
- 140 TABLET in 1 BOTTLE, PLASTIC (71335-9701-9) · 71335-9701-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →